| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.33 | 0.04 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.26 | 0.04 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |